| 000 | 01867 a2200541 4500 | ||
|---|---|---|---|
| 005 | 20250517130132.0 | ||
| 264 | 0 | _c20170906 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1558-8238 | ||
| 024 | 7 |
_a10.1172/JCI84262 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aCao, Juxiang | |
| 245 | 0 | 0 |
_aTuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. _h[electronic resource] |
| 260 |
_bThe Journal of clinical investigation _c01 2017 |
||
| 300 |
_a349-364 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAlleles |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlycogen Synthase Kinase 3 beta _xgenetics |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMechanistic Target of Rapamycin Complex 1 |
| 650 | 0 | 4 |
_aMelanins _xbiosynthesis |
| 650 | 0 | 4 |
_aMelanocytes _xmetabolism |
| 650 | 0 | 4 |
_aMicrophthalmia-Associated Transcription Factor _xgenetics |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultiprotein Complexes _xgenetics |
| 650 | 0 | 4 | _aMutation |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-akt _xgenetics |
| 650 | 0 | 4 | _aSignal Transduction |
| 650 | 0 | 4 | _aSkin Pigmentation |
| 650 | 0 | 4 |
_aTOR Serine-Threonine Kinases _xgenetics |
| 650 | 0 | 4 |
_aTuberous Sclerosis _xgenetics |
| 650 | 0 | 4 | _aTuberous Sclerosis Complex 1 Protein |
| 650 | 0 | 4 | _aTuberous Sclerosis Complex 2 Protein |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 650 | 0 | 4 |
_abeta Catenin _xgenetics |
| 700 | 1 | _aTyburczy, Magdalena E | |
| 700 | 1 | _aMoss, Joel | |
| 700 | 1 | _aDarling, Thomas N | |
| 700 | 1 | _aWidlund, Hans R | |
| 700 | 1 | _aKwiatkowski, David J | |
| 773 | 0 |
_tThe Journal of clinical investigation _gvol. 127 _gno. 1 _gp. 349-364 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1172/JCI84262 _zAvailable from publisher's website |
| 999 |
_c26667129 _d26667129 |
||